CNBX Pharmaceuticals Inc. (CNBX) Receivables - Other (2019 - 2021)

CNBX Pharmaceuticals' (CNBX) quarterly Receivables - Other came in at $8147.0 in Q1 2021, up 100.19% on a QoQ basis from -$4.4 million in Q4 2019.

CNBX Pharmaceuticals Inc. (CNBX) Receivables - Other (2019 - 2021) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 2 years of Receivables - Other data on file, last reported at $8147.0 in Q1 2021.

Quarterly Receivables - Other changed N/A year-over-year to $8147.0 in Q1 2021, while the trailing twelve-month figure through Feb 2021 was $8147.0 (changed N/A YoY) and the FY2020 annual result came in at -$4.4 million, down 200.0% from the prior year.
Receivables - Other advanced to $8147.0 in Q1 2021, from -$4.4 million in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $8147.0 in Q1 2021 to a low of -$4.4 million in Q4 2019.

Download Data